These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3229870)

  • 1. Pharmacokinetics of nilvadipine after single oral doses in healthy volunteers.
    Cheung WK; Woodward DL; Shin K; Hibberd M; Pearse S; Desjardins RE; Yacobi A; Silber BM
    Int J Clin Pharmacol Res; 1988; 8(5):299-305. PubMed ID: 3229870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of (+)- and (-)-nilvadipine after oral dosing with racemic (+)-nilvadipine in man.
    Tokuma Y; Fujiwara T; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):229-37. PubMed ID: 3659571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
    Wu WH; Henderson BM; Lanc R; Garnes D; Yacobi A; Silber BM
    Drug Metab Dispos; 1988; 16(2):222-7. PubMed ID: 2898337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food interaction pharmacokinetic study of cordaflex 20 mg retard filmtablet in healthy volunteers.
    Balogh Nemes K; Horváth V; Grézal G; Horvai G; Hrabéczy-Páll A; Kocsi E; Drabant S; Csörgö M; Renczes G; Klebovich I
    Int J Clin Pharmacol Ther; 1998 May; 36(5):263-9. PubMed ID: 9629990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
    Cho HY; Moon JD; Lee YB
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and electroencephalographic effects of darodipine 50-200 mg modified release (MR) acute oral administration: dose-finding study in healthy volunteers.
    Sannita WG; Busico S; Di Bon G; Ferrari A; Riela S
    Int J Clin Pharmacol Res; 1993; 13(5):281-91. PubMed ID: 8200723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity.
    Kharasch ED; Hoffer C; Walker A; Sheffels P
    Clin Pharmacol Ther; 2003 Mar; 73(3):199-208. PubMed ID: 12621385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone has no clinically significant effect on nifedipine pharmacokinetics.
    Harris RZ; Inglis AM; Miller AK; Thompson KA; Finnerty D; Patterson S; Jorkasky DK; Freed MI
    J Clin Pharmacol; 1999 Nov; 39(11):1189-94. PubMed ID: 10579151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.
    Algorta J; Pena MA; Alvarez A; Maraschiello C; Maruhn D; Windisch M; Mucke HA
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M; Chang S; Hellriegel ET
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and safety of recombinant human parathyroid hormone (1-34) (teriparatide) after single ascending doses in Chinese healthy volunteers.
    Chu NN; Li XN; Chen WL; Xu HR
    Pharmazie; 2007 Nov; 62(11):869-71. PubMed ID: 18065105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, safety, and tolerability of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist after oral administration at single and multiple once-daily ascending doses in healthy volunteers.
    Hijazi Y; Welker H; Dorr AE; Tang JP; Blain R; Renzetti LM; Abbas R
    J Clin Pharmacol; 2004 Dec; 44(12):1368-78. PubMed ID: 15545307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of nilvadipine in healthy volunteers.
    Terakawa M; Tokuma Y; Shishido A; Noguchi H
    J Clin Pharmacol; 1987 Feb; 27(2):111-7. PubMed ID: 3680562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nifedipine pharmacokinetics in liver cirrhosis patients after the administration of a single oral dose].
    Leucuţa SE; Grigorescu M; Dumitraşcu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1990; 42(2):185-90. PubMed ID: 1982192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.